Dilation Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
monday.com
MNDY
|
+$9.91M |
| 2 |
CYBR
CyberArk
CYBR
|
+$9.6M |
| 3 |
Celestica
CLS
|
+$8.05M |
| 4 |
NVIDIA
NVDA
|
+$7.16M |
| 5 |
Applovin
APP
|
+$6.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$4.99M |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.24M |
| 3 |
APi Group
APG
|
+$3.15M |
| 4 |
Howmet Aerospace
HWM
|
+$2.75M |
| 5 |
Sherwin-Williams
SHW
|
+$708K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Industrials | 28.84% |
| 3 | Financials | 12.56% |
| 4 | Utilities | 10.48% |
| 5 | Communication Services | 10.45% |
Similar funds
Dilation Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Dilation Capital Management held 23 positions worth $188M, up 128% from $82.3M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Dilation Capital Management deployed $68.5M of net new capital in Q2 2025, opening 8 new positions and adding to 9 existing holdings. Its largest new stake was monday.com: 35,590 shares worth $11.2M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Howmet Aerospace, an estimated $2.75M trimmed.
- Dilation Capital Management's largest Q2 2025 buy was monday.com: 35,590 shares worth $11.2M.
- Dilation Capital Management added most to NVIDIA in Q2 2025, an estimated $7.16M increase.
- Dilation Capital Management's biggest Q2 2025 reduction was Howmet Aerospace, cutting an estimated $2.75M.
- Dilation Capital Management fully exited Vertiv in Q2 2025, selling an estimated $4.99M.
- Dilation Capital Management's ten largest holdings make up 67% of its $188M portfolio in Q2 2025.
- Dilation Capital Management opened 8 new positions and closed 3 in Q2 2025.
- Dilation Capital Management's portfolio value rose 128% quarter-over-quarter to $188M.
Based on Dilation Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.